Suspension of Dividend Reinvestment Plan
Given the company’s strong performance over the last five years and reduction of debt to below the target gearing range, on 24 May 2019 the Board determined to suspend the dividend reinvestment plan (DRP). As a result, shareholders who have previously elected to participate in the DRP will receive dividends in cash for the 2019 final dividend and future dividends until such time as the Board determines otherwise.
History of Dividend Reinvestment Plan
Fisher & Paykel Healthcare established a dividend reinvestment plan (DRP) in 2009 under which shareholders were previously able to elect to reinvest all or part of their cash dividends in additional Fisher & Paykel Healthcare shares. The DRP was suspended in May 2019.
The DRP Offer Document below explains how the plan operated.
Dividend Reinvestment Plan Offer Document